Aardvark Therapeutics Inc (AARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 12-2022 | |
| Operating Expenses | 5,091 | 6,073 | 2,171 | 0 | 0 |
| Operating Income | -5,091 | -6,073 | -2,171 | N/A | N/A |
| Other Income | 909 | 624 | -7 | 0 | 0 |
| Pre-tax Income | -4,182 | -5,449 | -2,178 | 0 | 0 |
| Net Income Continuous | -4,182 | -5,449 | -2,178 | N/A | N/A |
| Net Income | $-4,182 | $-5,449 | $-2,178 | $N/A | $N/A |
| EPS Basic Total Ops | -1.05 | -1.37 | -0.55 | N/A | N/A |
| EPS Basic Continuous Ops | -1.05 | -1.37 | -0.55 | N/A | N/A |
| EPS Diluted Total Ops | -1.05 | -1.37 | -0.55 | N/A | N/A |
| EPS Diluted Continuous Ops | -1.05 | -1.37 | -0.55 | N/A | N/A |
| EBITDA(a) | $-5,091 | $-6,073 | $-2,169 | $N/A | $N/A |